Precision Medicine
Scientists at Weill Cornell Medicine say the new genome sequencing test to detect mutations can guide precision cancer treatment with more than 95 percent accuracy.
Population health management, EHRs and biosensing technologies were also among the top investment areas.
Carefluence OpenAPI proved to be compliant with Office of the National Coordinator criteria by using the FHIR standard. The application programming interface also can used with EHRs for open access.
